Back to results
US 2021/0332131 A1Published application
COMPOSITIONS AND METHODS COMPRISING IgA ANTIBODY CONSTRUCTS
AssigneesTigaTX, Inc., UMC Utrecht Holding B.V.
InventorsMark De Boer, Jeannette Henrica Wilhelmina LEUSEN, Geert Jan VAN TETERING
Life of this patent
Estimating the term…
Abstract
Provided herein are therapeutic agents, pharmaceutical compositions, and methods comprising an IgA constant region. The compositions and methods described herein facilitate binding of an antibody construct comprising an IgA constant domain to CD47 and an antigen for instance a tumor related antigen such as CD20 or CD19.
Claims1
An antibody construct comprising;
- (a) an immunoglobulin A (IgA) heavy chain domain;
- (b) a CD47 binding domain;
- and
- (c) an antigen binding domain;
- wherein the IgA heavy chain domain specifically binds a FcαR on an immune effector cell,
- wherein the CD47 binding domain inhibits binding of a CD47 expressed on a target cell with a signal regulatory protein α (SIRP α) on the immune effector cell,
- wherein the antigen binding domain binds an antigen on the target cell, and
- wherein the antibody construct has a higher binding affinity for the antigen compared to the CD47.
5 more elements
Dependencies are inferred from the claim text.